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Abstract
FGF signaling is a potent inducer of lacrimal gland development in the eye, capable of trans-
forming the corneal epithelium into glandular tissues. Here, we show that genetic ablation of
the Pea3 family of transcription factors not only disrupted the ductal elongation and branch-
ing of the lacrimal gland, but also biased the lacrimal gland epithelium toward an epidermal
cell fate. Analysis of high-throughput gene expression and chromatin immunoprecipitation
data revealed that the Pea3 genes directly control both the positive and negative feedback
loops of FGF signaling. Importantly, Pea3 genes are also required to suppress aberrant
Notch signaling which, if gone unchecked, can compromise lacrimal gland development by
preventing the expression of both Sox and Six family genes. These results demonstrate that
Pea3 genes are key FGF early response transcriptional factors, programing the genetic
landscape for cell fate determination.
Author summary
FGF signaling regulates cell fate decision by inducing genome-wide changes in gene
expression. We identified Pea3 family transcription factors as the key effectors of FGF sig-
naling in reprograming the epithelia transcriptome. Pea3 factors control both the feed-
back and feedforward circuities of FGF signaling in lacrimal gland development. They
also activate specific expression of Six and Sox family genes and suppress aberrant activa-
tion of Notch signaling. In the absence of Pea3 genes, the lacrimal gland progenitors
become epidermal-like in their gene expression patterns. The study of Pea3 function
resolves the long standing conundrum of how FGF induces the lacrimal gland fate, pro-
viding direction for regenerating the lacrimal gland to treat dry eye diseases.
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Introduction
During development of a complex multicellular organism, organ identity is determined by the
combination of lineage-specific and signal-induced transcription factors. In mammalian lacri-
mal gland development, the extracellular signals include Fibroblast Growth Factor (FGF),
Bone Morphogenetic Protein (BMP), Notch and Wnt that either cooperate or antagonize each
other during budding, elongation and branching morphogenesis [1]. In particular, genetic evi-
dence has revealed that FGF signaling initiated by the binding of FGF10/Fgf10, sent from the
periocular mesenchyme, to FGFR2B/Fgfr2b on the conjunctival epithelium is indispensable
for lacrimal gland development in both human and mouse [2–5]. Demonstrating the striking
potency of FGF signaling in driving the lacrimal gland fate, ectopic expression of either rat
Fgf10or human FGF7 in the lens led to the formation of lacrimal gland-like cells in an area
that under normal physiological conditions develops into the planar corneal epithelium [6, 7].
This is at least partly mediated by both the FGF-induced Sox9 expression required for lacrimal
gland induction and the Sox10 expression for acini formation [8]. However, unlike BMP,
Notch and Wnt which have well established downstream transcription effectors Smad, NICD
and β-catenin, respectively, how FGF signaling triggers its transcriptional responses in lacrimal
gland cell fate determination is not known.
The Pea3 family of transcription factors, composed of Pea3 (Etv4), Erm (Etv5) and Er81
(Etv1), are E26 transformation-specific (ETS)-domain proteins that can be phosphorylated by
Mitogen-Activated Protein Kinase (MAPK) to control their subcellular localization, DNA
binding and transactivation [9]. They have been shown to act as oncogenes in melanoma,
breast, lung and prostate cancer, mimicking the aberrant activation of RAS-MAPK pathways
commonly present in a multitude of malignancies [10]. During embryonic development,
expression of the Pea3 genes closely correlates with the activities of FGFs, making these genes
suitable candidates for being the downstream effectors of FGF-Ras-MAPK signaling [11, 12].
Indeed, conditional inactivation of Pea3/Erm in the lung epithelium disrupted the Fgf10-Shh
feedback loop, resulting in smaller lung sizes, but mice were grossly healthy and exhibited nor-
mal life-span [13, 14]. In the limb buds, Pea3 and Erm mediate FGF signaling in the proximal-
distal (P-D) and anterior-posterior (A-P) patterning, which was evident by the growth retarda-
tion and mild polydactyly in the Pea3/Erm mutants [15, 16]. Nevertheless, these Pea3/Erm
mutant phenotypes were relatively modest compared to the FGF signaling mutants in the
same tissues.
In this study, we show that the MAPK-regulated Pea3 family of transcription factors are
critical for lacrimal gland duct elongation and branching. Deletion of all three Pea3 genes
from the lacrimal gland epithelium resulted in ectopic expression of epidermal markers, shift-
ing the lacrimal gland progenitor cells toward a cutaneous cell fate. In addition to previously
reported FGF signaling response genes, we also identify Six1 and Six2 as being novel targets of
the FGF-Pea3 axis, showing that these two genes cooperate in regulating lacrimal gland
branching. Loss of Pea3 results in aberrant upregulation of Notch signaling in the lacrimal
gland primordia driven by Jag1-mediated lateral activation and concurrent downregulation of
the Notch modulator, lunatic fringe. Aberrant Notch signaling sustains this auto-stimulatory
loop by upregulating Jag1 expression, leading to the downregulation of FGF signaling effector
genes and failure of lacrimal gland induction. The shift of cellular identity and discordance of
FGF-Notch crosstalk in the absence of Pea3 transcription factors establishes Pea3 genes as cell
fate determinants in lacrimal gland development.
Pea3 promotes the lacrimal gland fate
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Results
Lacrimal gland development requires Pea3 transcription factors
Mouse lacrimal gland development commences at E13.5 with the thickening of the conjuncti-
val epithelium, which subsequently forms a bud, entering the surrounding periocular mesen-
chyme by E14.5. This process is triggered by the mesenchymal release of Fgf10 which activates
FGF signaling in the epithelium. This signaling leads to the activation of the Pea3 family of
ETS transcription factors, Pea3/Etv4, Erm/Etv5, Er81/Etv1 (Fig 1A–1C, dotted lines) [5, 17,
18]. We conditionally deleted Mek and Erk using an Le-Cre transgenic mouse line, in which
Cre-recombinase linked to an IRES-GFP reporter was expressed in the conjunctival epithe-
lium and the lacrimal gland [19]. In both Le-cre; Mek1fl/fl; Mek2-/- (Mek KO) and Le-cre; Erk1-/-;
Erk2fl/fl (Erk KO) lacrimal gland epithelia, expressions of Pea3 transcription factors were abol-
ished (Fig 1D–1I, dotted lines).
To study the function of these transcription factors, we conditionally deleted Erm and Er81,
two members of the Pea3 family of transcription factors, in a Pea3-null background using Le-
Cre. Indicated by the lacrimal gland progenitor cell marker Pax6, the lacrimal gland primordia
in E15.5 Le-cre; Pea3-/-; Ermfl/fl; Er81fl/fl (hereafter referred to as Pea3 TKO) embryos were
noticeably smaller in size compared to the control (Fig 1J and 1M, dotted lines). As reflected
by TUNEL staining, this was consistent with an increase in apoptosis seen in the lacrimal
gland primordia (Fig 1K and 1N, arrows). Analysis of the malformed gland marked by GFP
expression additionally showed that both duct elongation and branching were severely com-
promised at the post-natal P1 stage (Fig 1L and 1O, arrows). In contrast, the lacrimal gland
phenotype was considerably less severe in mice carrying at least one normal copy of Pea3 (Fig
1P), indicating the importance of Pea3 gene. Of note, unlike Mek and Erk KO that displayed
complete lacrimal gland aplasia, Pea3 TKO still presented with residual lacrimal glands. These
results suggest that Pea3 transcription factors mediate some but not all of MAPK-dependent
processes in lacrimal gland development.
Pea3 transcription factors fine tune FGF signaling
In order to decipher the gene regulatory network of Pea3 transcription factors, E14.5 lacrimal
gland epithelial tissue from control (Le-Cre) and mutant (Pea3 TKO) mouse embryos were
micro-dissected using laser capture microscopy and subjected to RNA-seq (Fig 2A, n = 3 per
condition). Unsupervised clustering analysis of the normalized data revealed that control and
mutant samples were separated into two distinctive groups and that data from individual sam-
ples within each group were highly correlated (Fig 2B, r = 0.8), indicating the robustness of the
obtained results. Gene ontology analysis showed that biological processes such as protein deg-
radation, ECM interaction, glycosaminoglycan biosynthesis and cell adhesions are signifi-
cantly downregulated in Pea3 TKO mutants (Fig 2C), which is in line with the previous
findings that proteoglycans and ECM proteins play important roles in lacrimal gland develop-
ment [5, 8, 17, 18]. In addition, PI3K and Ras pathways were also impaired in Pea3 TKO
mutants, suggesting that downstream effectors of FGF signaling may also be compromised. To
validate this idea, we compared our dataset with the previously published result from the Fgfr2
conditional knockout [8]. Gene set enrichment analysis (GSEA) revealed that there was indeed
a significant overlap in downregulated genes between Pea3 TKO and Fgfr2mutants (NES =
-6.8, p = 0.01) (Fig 2D) [20]. Taken together, these results are consistent with the notion that
the Pea3 family of genes act downstream of the FGF signaling cascade.
Further analysis revealed that Pea3 transcription factors were uniquely positioned to fine
tune the FGF signaling outcome. First, Pea3 transcription factors promoted their own
Pea3 promotes the lacrimal gland fate
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expressions in the lacrimal gland bud, as Pea3, Erm and Er81 transcripts were reduced in Pea3
TKO RNA-seq dataset (Fig 3A). Second, expression of heparan sulphate biosynthetic enzymes
Ext1, Hs3st and Hs6st was also down regulated (Fig 3A). Since heparan sulphate proteoglycans
are known to act as co-receptors for Fgf10, this was expected to dampen the positive feedback
mechanism of FGF signaling. Third, Pea3 transcription factors were required for the expres-
sion of Dusp6 and Spry4 (Fig 3A), which are both inhibitors of Ras-MAPK signaling. Reevalu-
ating the available ChIP-seq data from the human LoVo and GIST48 cancer cell lines [21, 22],
Fig 1. MAPK-regulated Pea3 transcription factors are required for lacrimal gland development. (A-I) Inactivation
of Mek and Erk signaling abolished expression of the Pea3 family of transcription factors, Pea3, Erm and Er81, in the
E14.5 lacrimal gland epithelium. (J, M) Lacrimal gland specific ablation of Pea3/Erm/Er81 genes resulted in a smaller
lacrimal gland bud as indicated by Pax6 expression. The lacrimal gland buds are marked by dotted lines. (K, N)
TUNEL staining indicated an increase in apoptosis in the Pea3 TKO lacrimal gland bud (arrows). (L, O) At the P1
stage, Pea3 TKO mutants displayed a residual lacrimal gland as shown by the GFP reporter. (P) Quantification of the
lacrimal gland phenotype in Pea3 TKO mutants at P1. Scale bars, 50μm.
https://doi.org/10.1371/journal.pgen.1007660.g001
Fig 2. Bioinformatics analysis indicates that Pea3 transcription factors are downstream of FGF signaling during lacrimal
gland development. (A) Images of sections before and after laser capture microscopy to isolate the lacrimal gland bud. Scale bar,
50μm. (B) Clustergram analysis of the top 200 differentially expressed genes in RNA-seq data from 6 different samples (Control,
n = 3, Mutant, n = 3). The control and mutant samples were segregated into two separate clusters, indicating the robustness of our
data (r = 0.8). (C) KEGG pathway analysis of downregulated genes in Pea3 mutant using DAVID indicated that several key
pathways were significantly downregulated. (D) Gene set enrichment analysis (GSEA) analysis showed that the transcriptome
changes in Pea3 mutants resemble that of the previously reported Fgfr2mutant.
https://doi.org/10.1371/journal.pgen.1007660.g002
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we found that all of the above negative and positive feedback genes could be bound by either
PEA3, ERM or ER81 in their promoter (within 5000 bp of the transcriptional start site) and/or
enhancer regions (beyond 5000 bp upstream or downstream to the promoter site) (Fig 3A and
3B). Many of the ChIP-seq peaks for PEA3 proteins overlapped with H3K4Me1, H3K4Me3
and DNAse I sensitivity sites, signifying an open chromatin conformation in these regions
Fig 3. Pea3 induces both the feedback and feedforward circuits in FGF signaling. (A) The heatmap of Pea3-dependent genes involved in feedforward and feedback
regulation of FGF signaling. P: promoter region, E: enhancer region. (B) Analysis of ChIP-seq data in the LoVo and GIST48 cancer cells line showed binding sites for
the Pea3 transcription factors in the promoter and enhancer regions of Pea3, Dusp6 and Col2a1. (C) The Pea3-dependent genes confirmed by RNA in situ hybridization
and immunostaining in the lacrimal gland bud (dotted lines). Arrows indicate the basement membrane staining of Col2a1. Scale bars, 50μm.
https://doi.org/10.1371/journal.pgen.1007660.g003
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(Fig 3B). Since Erm was the most highly expressed Pea3 transcription factor during lacrimal
gland development (Fig 1B), we searched for the putative Erm binding sites in the correspond-
ing mouse genomic regions using TRANSFAC database (S1 Fig). By chromatin immunopre-
cipitation, we confirmed that Erm protein indeed bound to the Ext1,Dusp6, Col2a1 and
Mmp2 loci in P4 lacrimal gland cells (S1 Fig). In addition, RNA in situ hybridization experi-
ments confirmed that Pea3, Erm, Er81 and Dusp6 genes were down regulated specifically in
the Pea3 TKO lacrimal gland primordia (Fig 3C). These data show that Pea3 transcription fac-
tors play a central role in modulating the levels of FGF signaling by regulating the positive and
negative feedback loops involved in the fine tuning of this pathway.
The lacrimal gland progenitors were biased toward the epidermal fate in
Pea3 mutants
The Sox family of transcription factors Sox9 and Sox10 have been previously identified as
downstream targets of FGF signaling important for lacrimal gland development [8]. The
expression levels of Sox10 were severely diminished in Pea3 TKO mutants, whereas the reduc-
tion in Sox9 expression was less dramatic (Fig 3A and 3C). Interestingly, the ChIP-seq analysis
suggested that the promoter of SOX9 but not that of SOX10 harbored direct binding sites for
PEA3 factors (Fig 3A). Sox9 was previously shown to regulate the expression of extracellular
matrix related genes Col2a1, Col9a1, Mia1 and MMP2, which is consistent with the dynamic
remodeling of the extracellular matrix during lacrimal gland development [8]. Interestingly,
these genes were also occupied by PEA3 transcription factors in their promoter/enhancer
regions in GIST48 and LoVo cells, with their expressions being down regulated in Pea3 TKO
mutants (Fig 3A–3C). Therefore, by controlling both Sox9 and its downstream targets,
Pea3 transcription factors activate a feedforward mechanism in regulating lacrimal gland
development.
Strikingly, the transcriptome analysis additionally revealed that many keratin genes were
upregulated in Pea3 TKO mutants (Fig 4A). This result was especially unexpected because the
keratins that were ectopically expressed are typically found in the cutaneous epithelium during
embryonic development, rather than in the lacrimal gland. This led us to hypothesize that
there was a shift in cell identity from the lacrimal gland fate to the epidermal-like fate in the
absence of Pea3 genes. To test this idea, we performed GSEA of differentially upregulated
genes in Pea3 TKO mutants compared to the published gene expression datasets of E14.5
mouse embryonic skin [23]. This analysis showed that the transcriptome of the Pea3 TKO lac-
rimal gland primordia was significantly enriched in genes prevalent in the epidermis (Fig 4B,
NES = 11.99, p<0.001) and hair follicle placode (NES = 9.0, p<0.01). In contrast, no signifi-
cant similarities were observed when compared with the dermal condensates, skin fibroblast,
melanocyte or Schwann cells. We next examined a set of genes that displayed nested expres-
sions from the epidermis, to the conjunctiva to the lacrimal gland. At E14.5, Krt14 was mostly
restricted to the epidermis, and Krt5 and Sfn were only present in the skin epidermis and the
conjunctival epithelium, whereas Krt7 expression was expanded into the stalk region of the lac-
rimal gland but excluded from the bud (Fig 4C). In the Pea3 TKO mutant, all these genes were
expressed in the lacrimal gland primordia. These data indicated that Pea3 proteins prevented
the lacrimal gland progenitors from adopting the epidermal fate.
Six1 and Six2 cooperate to regulate branching morphogenesis downstream
to FGF-Pea3 signaling
To further understand the molecular mechanism of Pea3 mutant defects, we sought to deter-
mine the most differentially regulated genes in our dataset. For this analysis, the gene
Pea3 promotes the lacrimal gland fate
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expression changes depicted by Log2 (fold change) were plotted on the x-axis against the corre-
sponding statistical significance depicted by -Log10 (p-value) on the y-axis (Fig 5A). Apart
from the aforementioned FGF-responsive genes Spry4, Dusp6, Col2a1, Col9a1, Sox9 and Sox10,
transcription factors Six1 and Six2 also emerged as significantly downregulated genes in Pea3
TKO mutants. Importantly, both SIX1 and SIX2 loci in GIST48 and LoVo cells displayed sig-
nificant ChIP-seq peaks for PEA3, Erm and ER81 in open chromatin conformations marked
by histone H3K4Me1 and H3K4Me3 methylations and DNase I sensitivity, suggesting they
could be direct targets of PEA3 transcription factors (Fig 5B). Indeed, in situ hybridization for
Six1/ Six2 revealed that their expressions were significantly reduced in E14.5 Pea3 TKO lacri-
mal glands (Fig 5C, dotted lines) and abolished in Le-Cre; Fgfr2fl/flmutants (Fig 5C, arrows).
Therefore, Six1 and Six2 are transcriptional targets of Pea3 and FGF signaling in the lacrimal
gland epithelium.
While a Six1 deletion has been shown to affect lacrimal gland duct elongation and branch-
ing [24], a Six2 mutant phenotype hasn’t previously been reported. We examined lacrimal
gland development in Six2 knockout embryos at E15.5, but did not observe any gross abnor-
malities (S2 Fig). This could be due to compensation by Six1 during lacrimal gland develop-
ment. To test this idea, we used siRNAs against Six1 and Six2 genes, which resulted in
Fig 4. Loss of Pea3 disrupted the adoption of the lacrimal gland fate. (A) A list of genes typically expressed in the
cutaneous epithelium that were upregulated in the Pea3 TKO lacrimal gland bud. (B) GSEA analysis of differentially
upregulated genes in the Pea3 TKO mutants showed a strong resemblance to the epidermal gene signature. (C) Ectopic
expression of Krt14, Krt5, Sfn and Krt7 in the Pea3 mutant lacrimal gland. Scale bars, 50μm.
https://doi.org/10.1371/journal.pgen.1007660.g004
Pea3 promotes the lacrimal gland fate
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significant down regulation of their expressions in a cell based assay (Fig 5D). In the ex-vivo
lacrimal gland culture, exogenous Fgf10 induced significant growth of the E17.5 lacrimal
gland primordia, which was dampened by siSix1 but not by scrambled siRNA (Fig 5E and 5F).
Fig 5. Six1 and 2 are downstream targets of Pea3. (A) Volcano plot of dysregulated genes in Pea3 mutant lacrimal gland buds. Red dots highlight Six1, Six2 and
other known targets of FGF signaling down regulated in Pea3 mutants. (B) Pea3 binding sites were presented in the Six1 and Six2 loci as shown by analysis of ChIP-
seq datasets. (C) Both Six1 and 2 were downregulated in Pea3 and Fgfr2mutants. Scale bar, 50μm. (D) Quantitative-PCR demonstrated that siRNA reduced the
expressions of Six1 and Six2. Student’s t test, P<0.01, P<0.0001, n = 3. (E-F) siRNA knockdown of Six1 and Six2 synergistically disrupted lacrimal gland
development in explant lacrimal gland cultures (Mean lacrimal gland sizes relative to control + s.e.m. are shown. One-way ANOVA test, P<0.05, P<0.02, n = 3 for
each condition).
https://doi.org/10.1371/journal.pgen.1007660.g005
Pea3 promotes the lacrimal gland fate
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Although siSix2 did not display any effect, combined application of siSix1 and siSix2 led to sig-
nificant reduction in the size of lacrimal gland buds induced by Fgf10. These results show that
Six1 and Six2 act synergistically to regulate lacrimal gland development.
Pea3 transcription factors suppressed Notch signaling to promote lacrimal
gland induction
Although Pea3 proteins generally function as transcriptional activators, they can also act as
repressors in certain contexts [25], thus we examined genes upregulated in the Pea3 TKO
mutants. Notably, pathway analysis revealed activation of the Notch signaling pathway
reflected by an increase in expression of the ligand Jag1, receptors Notch1, Notch 2 and
Notch3, downstream target Hes1 and a reduced expression of Lunatic fringe (Lfng) (Fig 6A).
This was further confirmed by GSEA of Notch signaling genes in the Pea3 TKO transcriptome
(Fig 6B). Indeed, RNA in situ hybridization showed that Jag1 mRNA was normally restricted
to the surface ectoderm and conjunctiva at E14.5, but in the Pea3 TKO mutants, Jag1 tran-
scripts were ectopically expressed in the lacrimal gland primordia, with its translated protein
Fig 6. Notch signaling was induced in the Pea3 mutant lacrimal gland. (A-B) GSEA analysis and Volcano plot data revealed
that Notch pathway genes were enriched in Pea3 mutants. (C) The Pea3 knockout resulted in loss of the Notch regulator Lfng,
induction of ligand Jag1 and ectopic expression of the effector, Notch-ICD, in the lacrimal gland bud (dotted lines). Scale bar,
50μm.
https://doi.org/10.1371/journal.pgen.1007660.g006
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form being prominently induced in the same area (Fig 6C). This was in sharp contrast to Lfng,
a gene that was readily detectable in the control lacrimal gland with its expression being signif-
icantly reduced in the Pea3 TKO mutants (Fig 6C). In line with these findings, Pea3 TKO
mutant lacrimal gland primordia displayed readily detectable staining patterns of Notch1
intracellular domain (Notch1-ICD), demonstrating that Notch signaling was aberrantly
activated.
After establishing the misplaced activation of Notch signaling in the lacrimal gland, we sub-
sequently investigated the functional significance of its activation in this developing tissue.
Lfng is a glycosyl transferase that prevents Jag1-mediated Notch signaling in a context depen-
dent manner [26–28]. Consistent with its negative role in Notch signaling, genetic ablation of
Lfng resulted in a moderate increase in Notch1-ICD staining in the tip of the E14.5 lacrimal
gland (S3A–S3D Fig). Interestingly, lacrimal gland size was reduced in P10 Lfng knockout
pups, suggesting that the loss of Lfng expression likely contributed to the Pea3 TKO lacrimal
gland phenotype (S3E and S3F Fig). Nevertheless, the Lfng knockout did not fully activate
Notch signaling to the extent seen in the Pea3 TKO mutants. This prompted us to directly
express the Notch1 intracellular domain in the developing lacrimal gland using the Cre-induc-
ible R26-N1CD allele. In E14.5 Le-Cre; R26-N1CD embryos, expressions of Six1 and Six2 were
lost, but the lacrimal gland progenitor cell markers Pax6 and E-cadherin were retained (Fig 7A
and 7B, dotted lines). The downstream targets of FGF signaling such as Sox10, Pea3, Erm and
Dusp6 were also downregulated (Fig 7A). Interestingly, Jag1 was upregulated in the fornix of
the conjunctiva where the lacrimal gland progenitors resided, suggesting that Notch signaling
acted in an auto-stimulatory loop to increase Jag1 expression (Fig 7B, dotted lines). At P1, no
lacrimal gland was found in Le-Cre; R26-N1CD embryos (Fig 7B, n = 10), demonstrating that
aberrant activation of Notch was deleterious to lacrimal gland development.
Discussion
FGF signaling plays an instructive role in lacrimal gland development, controlling its fate
determination and morphogenesis. Mediated by the canonical Ras-MAPK pathway, FGF sig-
naling induces expression of Pea3 transcription factors during the formation of both the epi-
thelial and mesenchymal compartments of the lacrimal gland [18, 29]. In this study, we
showed that Pea3 transcription factors were necessary to establish the identity of the lacrimal
gland epithelium, turning it away from epidermal and conjunctival cell fates (Fig 7C). This
was further attributed to the loss of Six1 and Six2 during lacrimal gland development, leading
to both the disruption of duct elongation and branching morphogenesis. In addition, we
found that Pea3 transcription factors inhibited the Notch signaling pathway which, when acti-
vated, prevents the expression of Six and Sox genes and causes the abortion of lacrimal gland
induction. Collectively, our data demonstrate that Pea3 transcription factors control the
expression profiles of key genes involved in the promotion of lacrimal gland identity and
morphogenesis.
The regulatory mechanisms controlling the expression levels of Six1 and Six2 are not well
understood. Six1 deficiencies cause defects in organs that include the inner ear and kidney,
both of which also develop through an epithelial-mesenchymal interaction like that which
occurs in the lacrimal gland. However, contrary to what we observed in the lacrimal gland,
analyses of inner ear development showed that Pea3 negatively regulated the pre-placodal
genes Six1 and Eya2, and Six1 acted upstream of Jag1 in the Notch signaling pathway [30, 31].
In kidney development, both Six1 and Six2 are expressed in the cap mesenchymal area
where they are required for the ureteric budding and branching process [32–34]. Although
Pea and Erm transcription factors are present in both the ureteric bud and the mesonephric
Pea3 promotes the lacrimal gland fate
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mesenchyme, they are only required in the epithelial compartment to mediate Ret signaling
[35]. SIX1/Six1 have been previously implicated in lacrimal gland development in humans and
in mice. A heterozygous missense mutation in the SIX1 gene causes autosomal dominant lacri-
mal gland stenosis whereas Six1 knockout mouse embryos displayed small lacrimal glands
with duct elongation and branching defects [24]. Our RNA-seq analysis showed that Six2 was
expressed at 5.6 folds higher than Six1 in the developing lacrimal gland epithelium, but sur-
prisingly, Six2 null mutant embryos did not exhibit any lacrimal gland phenotype. This was
likely due to compensation by Six1, as our explant culture experiments showed that knock-
down of both Six1 and Six2 synergistically disrupted branching morphogenesis of the lacrimal
gland. We further showed that Six1 and Six2 were controlled by Pea3 transcription factors
downstream of FGF signaling in the lacrimal gland epithelium. Thus, Six1 and Six2 genes are
novel targets of Pea3 transcription factors in regulating lacrimal gland morphogenesis.
Although Notch activity is important for maintaining the postnatal homeostasis of the lacri-
mal gland [36], its temporal requirement during development has yet to be established. We
have shown that Pea3 transcription factors prevent ectopic activation of Notch signaling dur-
ing lacrimal gland induction. Analysis of our RNA-seq data for the modulators of Notch
Fig 7. Ectopic activation of Notch signaling abolished lacrimal gland development. (A) Ectopic induction of Notch signaling by Notch-ICD
overexpression abrogated many of the Pea3-regulated genes in the lacrimal gland bud (dotted lines). Scale bar, 50μm. (B) Notch-ICD overexpression did not
perturb lacrimal gland progenitor cell markers Pax6 and Ecad but resulted in the up regulation of Jag1 expression. At P1, no lacrimal gland was observed
(arrow). Scale bar, 50μm. (C) Schematic diagram of the Pea3-regulated genetic network in lacrimal gland development.
https://doi.org/10.1371/journal.pgen.1007660.g007
Pea3 promotes the lacrimal gland fate
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signaling showed that Lfng was the only Fringe family gene expressed abundantly in the lacri-
mal gland and its expression was significantly downregulated in the Pea3 TKO mutants. Lfng
is a glycosyltransferase that adds O-linked fucose residues to the extracellular domain of the
Notch receptor in order to modulate its ligand binding [37]. Lfng has been shown to potentiate
the Dll-mediated but inhibit the Jag1-mediated Notch1 signaling pathways [26–28]. During
sensory hair cell development in the inner ear, Lfng co-expresses with Jag1 and, when mutated
in mice, partially rescues the Jag2 knockout phenotype [38, 39]. During lacrimal gland devel-
opment, Pea3 transcription factors may turn on the expression of Lfng to down regulate Jag1--
mediated Notch signaling. This model was supported by the down regulation of Lfng levels in
the absence of Pea3 transcription factors, and increased Notch1-ICD staining with reduced
size of the lacrimal gland in the Lfng knockout. Lfng was not the only component of Notch sig-
naling targeted by the Pea3 transcription factors in the lacrimal gland. In fact, the expression
levels of Jag1, Notch and Hes1 were all elevated in the Pea3 TKO mutants, resulting in a much
higher level of Notch1-ICD staining compared to that seen in the Lfng mutants. To replicate
such strong activation of Notch signaling, we directly expressed Notch1-ICD in the ocular sur-
face, resulting in loss of both the Six and Sox genes and abrogation of lacrimal gland induction.
These results highlight the importance of inhibiting aberrant premature Notch signaling dur-
ing lacrimal gland development.
Our study revealed a previously underappreciated FGF signaling network systematized by
the Pea3 transcription factors targeting Sox, Six and Notch signaling pathways during develop-
ment of the lacrimal gland. We also showed that Pea3 transcription factors not only directly
promote the expression of heparan sulfates involved in potentiating FGF signaling but also
activate expression of the inhibitory factors Sprouty4 and Dusp6. We would like to suggest
that by inducing both positive and negative feedback loops the Pea3 family of proteins may
amplify the transcription response to low levels of FGF signaling but dampen the response to
strong FGF signals. This non-linear transcriptional response mechanism can stabilize the FGF
signaling network output given a wide range of FGF signal input, buffering the developmental
system in face of environmental perturbations.
Materials and methods
Ethics statement
The animal experiments were approved by Columbia University Institutional Animal Care
and Use Committee (Protocol number: AAAR0429).
Mice
Mice carrying Erk1-/-, Erk2flox, Lfng-/-,Mek1flox and Mek2-/- alleles were bred and genotyped as
described [28, 40, 41]. We obtained Er81flox mice from Dr. Silvia Arber (University of Basel,
Basel, Switzerland), Pea3-/- and Ermflox mice from Dr. Xin Sun (University of California at San
Diego, San Diego, CA), Fgfr2flox from Dr. David Ornitz (Washington University Medical
School, St Louis, MO) and Le-Cre mice from Dr. Ruth Ashery-Padan (Tel Aviv University, Tel
Aviv, Israel). [15, 19, 42, 43]. Rosa-N1-ICDflox/+ mice were obtained from Jackson lab (Stock #
008159). Animals were maintained in a mixed genetic background. Lacrimal gland growth
and morphology were identical in Le-Cre and Le-Cre;Pea3+/-;Ermflox/+;Er81flox/+ mice, which
were used as controls throughout the conducted experiments. Mice were housed in specific
pathogen free (SPF) facility that employed a 12-hour light-dark cycle and were given standard
mouse feed.
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RNA in situ hybridization
RNA in situ hybridization was performed as previously described [44]. Briefly, the mouse
embryos were harvested, fixed overnight in 4% PFA, equilibrated in 30% sucrose and cryo-
frozen in OCT. On the day of the experiment, OCT blocks were sectioned at 10 μm, hybridized
with the diluted probe at 68˚C overnight in a wet chamber and moistened with solution
containing 50% Formamide and 1X Salt (0.2M NaCl, 10mM Tris, 5mM NaH2PO4, 5mM
Na2HPO4, 5mM EDTA). The probe was diluted at 1:200–500 in a pre-warmed hybridization
buffer and incubated at 70˚C for at least 10 minutes. On the next day, slides were washed 3X in
wash buffer (1X SSC (150mM NaCl, 15mM Sodium citrate, pH 7), 50% Formamide) at 68˚C.
After cooling, slides were washed 2X with MABT (100mM maleic acid, 150mM NaCl, pH 7.5,
0.1% Tween 20) and incubated at room temperature for 30 min. Slides were then blocked with
20% Sheep serum in MABT for 1 hour, followed by an overnight incubation with anti-DIG
antibody (1:1500) at 4˚C. On the next day, slides were washed 4-5X with MABT and 2X with
alkaline phosphatase buffer. For color development, slides were covered with BM purple sub-
strate and incubated at room temperature for 4–24 hrs. The following probes were used: Pea3,
Erm5 (from Dr. Bridget Hogan, Duke University Medical Center, Durham, NC, USA), Er81
(from Dr. Gord Fishell, New York University Medical Center, New York, NY, USA), Jag1
(from Dr. Doris Wu, National Institute on Deafness and Other Communication Disorders,
National Institutes of Health, Bethesda, MD), Lfng (from Dr. Andy Groves, Baylor College of
Medicine, Houston, TX), Six1 (from Dr. Bernice Morrow, Albert Einstein College of Medicine,
New York, NY, USA), Six2 (from Dr. Thomas Caroll, UT Southwestern Medical center, Dallas,
TX, USA), Sox10 (from Dr. Anthony Firulli, Indiana University School of Medicine, Indianap-
olis, IN, USA), Dusp6 (full length cDNA IMAGE clone: 3491528, Open Biosystems, Huntsville,
AL, USA), Sfn and Krt7 (full length cDNA IMAGE clone: 184592 and 40614, the DNA
Resource Core, Harvard Medical School, Boston, MA, USA).
Immunohistochemistry
For immunohistochemistry of paraffin samples, sections were deparaffinized and rehydrated by
serial treatment with histosol followed by decreasing percentages of ethanol solutions [44, 45]. For
cryosections, sections were briefly washed with PBS to remove OCT. Antigen retrieval was per-
formed with microwave boiling in citrate buffer (10 mM sodium citrate, pH 6.0) for 1–2 minutes
followed by heating for 10 minutes at a low power setting. Sections were then washed with PBS
and blocked with 5% NGS/0.1% Triton in PBS. Primary antibody incubation was performed over-
night at 4˚C in a humid chamber followed by incubation with fluorescent-conjugated secondary
antibodies for 1 hour at room temperature in the dark. For signal amplification, HRP-conjugated
secondary antibodies were used, followed by washing and equilibration with TNT buffer. The
slides were then incubated with Tyramide reagent for 10 minutes, washed with TNT buffer,
stained with DAPI and mounted with anti-fade reagent, 0.2% NPG, 90% glycerol in 1X PBS. The
following primary antibodies were used: Pax6 (PRB-278P) and Krt14 (PRB-155P) (both from
Covance, Berkeley, CA, USA), Ecad (U3254, Sigma, St Louis, Missouri, USA), Jag1 (sc-8303, H-
114, Santa Cruz Biotechnology, Santa Cruz, CA, USA), Krt 5 (905901, Biolegend, San Diego, CA,
USA), N1-ICD (#4147, Cell signaling Technology, Boston, MA, USA)
Quantitative-PCR
3T3/HeLa cells were cultured in Dulbecco’s Modified Eagle’s Medium supplemented with 10%
fetal bovine serum and 1% penicillin/streptomycin (Invitrogen) at 37˚C. For the Six1 knockdown,
transient transfection of Six1 siRNA (s73792, Ambion, Carlsbad, CA) was performed in 3T3 cells.
Total RNA from 3T3 cells was extracted using the MiniRNA Plus kit (Qiagen, Hilden, Germany)
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and converted to cDNA using the High-Capacity cDNA Reverse Transcription Kit (Applied Bio-
systems, Foster City, CA). Quantitative-PCR was performed using the PCR SYBR green 2X mas-
ter mix (Invitrogen, Carlsbad, CA) in the StepOne plus Real time PCR instrument [46]. For the
Six2 knockdown, transient transfection of Six2 cDNA (clone TCM1304, Transomic, Huntsville,
AL) was performed with Lipofectamine 3000 (cat#L3000015, Invitrogen, Carlsbad, CA) according
to the manufacturer’s instruction. After 18 hours, cells were transfected with Six2 siRNA (Silencer
Select, s73794, Ambion, Carlsbad, CA) or scrambled siRNA with a final concentration of 20 nM
using RNAi Max (cat#13778150, Invitrogen, Carlsbad, CA) according to the manufacturer’s
instruction. siRNA silencing was conducted a second time after 8 hours. Cells were collected for
Quantitative-PCR analysis following the Six2 cDNA overexpression for 48 hours and the Six2
siRNA knockdown for 24 hours. The primer sequences used were: Six1: 5’- ATGCTGCCGTC
GTTTGGTT -3’, 5’-CCTTGAGCACGCTCTCGTT -3’, Six2: 5’- CACCTCCACAAGAATGAA
AGCG-3’, 5’-CTCCGCCTCGATGTAGTGC -3’, Gapdh: 5’-AGGTCGGTGTGAACGGATTT
G-3’, 5’-TGTAGACCATGTAGTTGAGGTCA-3’.
Chromatin immunoprecipitation
P4 old lacrimal glands collected from 40 mouse pups were incubated with 1ml trypsin for 5
minutes and pipetted a few times to dissociate into single cells. 4ml DMEM+10% FBS was
added to neutralize the trypsin before addition of 270μl formaldehyde (37%) in 10ml of DMEM
containing 10% FBS to fix the cells with shaking for 10 minutes. The cross linking was stopped
by addition of DMEM with 10% FBS and 0.125M glycine for 5 minutes. After washed with cold
1xPBS twice (5 minutes each) and centrifuged in 3000 rpm for 3 minutes, the cells were col-
lected and re-suspended in 1ml of ChIP lysis buffer (10mM Tris-Cl, pH8, 85mM KCl, 0.5% NP-
40, 5nM EDTA, 0.25% Triton; RIPA- 1% Triton, 150mM NaCl, 0.1% SDS, 0.1% Na-Deoxycho-
late, 10mM Tris-Cl, pH8, 5mM EDTA) with 1X protease inhibitor and kept in rocker at 4˚C for
10 minutes. The cells were spun at 3K rpm, re-suspended with 1ml of RIPA buffer with 1X pro-
tease inhibitor before being sonicated with the power 1 second “on”, 2 second “off” for 8 min-
utes and spun in 15000 rpm for 10 minutes at 4˚C. Pre-cleared by incubating with 45 μl agarose
beads for 2 hrs at 4˚C, the supernatant was spun at 3K rpm and incubated overnight with 1μg of
antibody for 1mg of protein at 4˚C, followed by 20 μl protein G bead for 2 hrs. The beads were
washed with RIPA, Wash buffer A (50mM HEPES, pH7.9, 500mM NaCl, 1mM EDTA, 1% Tri-
ton, 0.1% Na-deoxycholate, 0.1% SDS), wash buffer B (20mM Tris-Cl, pH8, 1mM EDTA, 250
mM LiCl, 0.5% NP-40, 0.5% Na-deoxycholate) and TE buffer twice respectively (5 min each
wash). After they were spun at 2000 rpm, the collected beads were incubated with 480μl elution
buffer (1% SDS, 30mM Tris-Cl (pH8), 15mM EDTA, 200mM NaCl) at 50˚C overnight before
adding the same volume of phenol:chloroform and centrifuging at 15000 rpm for 5 minutes.
The supernatant was mixed with 2X ethanol (100%) at -80˚C for 30 minutes, recovered to RT
and centrifuged at 15000 rpm at 4˚C for 15 minutes. The pellet was washed with 70% ethanol
and the air dried DNA was dissolved in 15μl of distilled water for PCR reaction. The mouse
monoclonal antibody against Erm was from Proteintech (Catalog number: 66657-1-Ig). The
primers used are: CAGCGACTGGAATGAGAACA and GCTGGAACAGGTTGTGTTGA for
Dusp6, ACTTGGGACTGCCACACTG and AACAACCCCCTCCCTTCTAA for Col2a1, TAC
GATGATGACCGGAAGTG and AGGTTGTTCCAGGTCAGGTG for Mmp2, AGTCCCGC
TTGATACCTTGA and GTGGCTTTCTCGCTGTCTTT for Ext1.
Lacrimal gland organ culture
The lacrimal glands from E16.5–17.5 embryos were harvested and gently transferred onto filter
paper (0.45 um) in 35 mm low bottom dishes (ibidi, Martinsried, Germany) in medium
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(DMEM, 5%FBS, 400ng/ml Fgf10, 250ng/ml Heparin, 1X ITS, P/S) containing either scram-
bled, Cy3-labeled negative control (AM4621, Invitrogen, Carlsbad, CA), Six1 (s73792) or Six2
(s73794) siRNA. Lipoefectamine-siRNA complexes were prepared in Optimem medium as per
the manufacturer’s instructions. To test the genetic redundancy, 45nM of scrambled siRNA,
15nM Six1 + 30nM scrambled siRNA, 30nM Six2 +15nM scrambled siRNA and 15nM Six1 +
30nM Six2 siRNA were used. 10μl of matrigel and medium in a 1:1 ratio was added on top of
each gland. The glands were cultured for 24–48 hrs at 37˚C.
Laser capture microdissection, RNA sequencing and Bioinformatics
analysis
Laser capture microdissection and RNA sequencing were performed as previously described
[29]. The RNAseq data is available at the GEO repository under accession number GSE11
4509. Unsupervised clustering analysis was performed in MATLAB using the Clustergram
function. We determined interquartile ranges of the gene expression levels in all samples and
the top 200 genes were plotted. GSEA was performed using MATLAB implementation of the
same method as described [20]. KEGG pathway enrichment analysis and functional annota-
tion was performed in DAVID. For the functional annotation of downregulated genes, a list of
476 genes was used for the analysis based on cutoff points for the normal expression levels
(> 50 units), Log2 (fold change) (<-1) and p-values (<0.05). Volcano plots representing Log2
(p-value) vs Log2(fold change) were plotted in MATLAB. -Log2(p-value) > 50 were set to 50
in order to avoid the scaling issues in the plot.
ChIP-seq analysis was performed using MACS [47]. SRA files of ETV1 (ER81), ETV4
(PEA3) and ETV5 (ERM) ChIP-seq data were retrieved from the GEO database [21, 22].
SRA files were converted to a Fastq format using sratoolkit, followed by mapping of the
sequence reads on the genome (hg18) to generate a SAM file. Peak calling was done using
MACS (using default parameters). The mapped ChIP-seq file was visualized on the human
reference genome assembly (hg18) using the UCSC genome browser. The Erm binding
sites in the mouse genome were scanned using MATCH algorithm based on TRANSFAC
database.
Supporting information
S1 Fig. Chromatin immunoprecipitation confirmed Erm target genes in the lacrimal gland
cells. (A) Locations of Erm binding sites (blue bars) identified by the TRANSFAC database in
Ext1,Dusp6, Col2a1 and Mmp3 mouse genes overlaid with the conservation plot of placental
mammal genomes. (B) Chromatin immunoprecipitation using anti-Erm antibody showed
selective enrichment of Ext1,Dusp6, Col2a1 and Mmp3 sequences compared to IgG antibody
control.
(TIF)
S2 Fig. Normal lacrimal gland development in the Six2-/- mutant. (A-B) Hematoxylin and
Eosin (H&E) and Pax6/Ecad staining showed comparable lacrimal gland budding between the
E15.5 control and Six2-/- mutant embryos (dotted lines).
(TIF)
S3 Fig. Lfng knockout resulted in up regulation of Notch signaling and lacrimal gland
hypoplasia. (A-D) Notch-ICD was elevated in the tip of the Lfng mutant lacrimal gland bud at
E14.5. C and D are the enlarged images of the areas marked in A and B. Arrows point to the
tips of the lacrimal gland buds. (E-F) At P10, the lacrimal gland in the Lfng mutant (F) was
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reduced in size compared to the wild type control (E).
(TIF)
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